Loading clinical trials...
Loading clinical trials...
Clinical Study to Evaluate the Efficacy, Pharmacokinetics and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Patients With Primary Immunodeficiency Diseases
Conditions
Interventions
NewGam
Locations
7
United States
Sudir Gupta, MD
Irvine, California, United States
Isaac Melamed, MD
Centennial, Colorado, United States
James Moy, MD
Chicago, Illinois, United States
William Smits, MD
Fort Wayne, Indiana, United States
Dr. Alan Knutsen
St Louis, Missouri, United States
Ai Lan Kobayashi, MD
Papillion, Nebraska, United States
Start Date
January 1, 2010
Primary Completion Date
June 1, 2012
Completion Date
June 1, 2012
Last Updated
March 16, 2017
NCT05755035
NCT06955793
NCT01218438
NCT01175213
Lead Sponsor
Octapharma
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions